Evidence map›Paper›PMID 39354109›Full record

ReviewVirchows Archiv : an international journal of pathology2024

Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology.

Marius Ilié, Vivien Lake, Enrique de Alava, Serena Bonin, Sandra Chlebowski, Aurélie Delort, Elisabeth Dequeker, Raed Al-Dieri, Arjan Diepstra, Olli Carpén and 19 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Liquid biopsy in solid tumours: expert opinion paper of the European society of pathology.Virchows Archiv : an international journal of pathology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Marius IliéLaboratory of Clinical and Experimental Pathology, Hospital-Related Biobank BB0033-00025, Nice University Hospital, University Côte d'Azur, FHU OncoAge, IHU RespirERA, 06000, Nice, France. ilie.m@chu-nice.fr.ORCID http://orcid.org/0000-0002-2014-1236
Vivien LakeCenter for Active Learning and MSc International Office, IDEX Université Côte d'Azur, Nice, France.
Enrique de AlavaInstitute of Biomedicine of Sevilla, IBiS/Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, 41013, Seville, Spain.
Serena BoninMolecular Histopathology Laboratory, DSM-Department of Medical Sciences, University of Trieste, Trieste, Italy.
Sandra ChlebowskiCenter for Active Learning and MSc International Office, IDEX Université Côte d'Azur, Nice, France.
Aurélie DelortCenter for Active Learning and MSc International Office, IDEX Université Côte d'Azur, Nice, France.
Elisabeth DequekerDepartment of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, University of Leuven, Kapucijnenvoer 7 blok g - bus 7001, 3000, Leuven, Belgium.
Raed Al-DieriEuropean Society of Pathology, Brussels, Belgium.
Arjan DiepstraDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Olli CarpénDepartment of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.
Catarina EloyPathology Laboratory, Institute of Molecular Pathology and Immunology of the University of Porto - IPATIMUP, Porto, Portugal.
Ambrogio FassinaPathology Department, Pathology Section of UEMS, University of Padova, Padova, Italy.
Falko FendInstitute of Pathology and Neuropathology, Tübingen University Hospital, Tübingen, Germany.
Pedro L FernandezPathology Department, Hospital Germans Trias i Pujol, IGTP, Autonomous University of Barcelona, Badalona, Spain.
Gregor GorkiewiczDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Simon HeekeDepartment of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rui HenriqueDepartment of Pathology and Cancer Biology and Epigenetics Group - CI-IPOP@RISE (Health Research Network) Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) & Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, Portuguese Oncology Institute of Porto (IPO Porto), University of Porto, Porto, Portugal.
Gerald HoeflerDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Pablo HuertasDepartamento de Genética, Universidad de Sevilla, Sevilla, Spain.
Michael HummelMolecular Diagnostics Institute of Pathology Charité, Universitätsmedizin Berlin, Berlin, Germany.
Karl KashoferDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Jeroen van der LaakDepartment of Pathology, Radboud University Medical Center, Nijmegen, Netherlands.
Rocio Martinez de PablosDepartamento de Genética, Universidad de Sevilla, Sevilla, Spain.
Fernando SchmittDepartment of Pathology, Faculty of Medicine of University of Porto, CINTESIS@-RISE, Health Research Network, Porto, Portugal.
Ed SchuuringDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Giorgio StantaDepartment of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, University of Leuven, Kapucijnenvoer 7 blok g - bus 7001, 3000, Leuven, Belgium.
Wim TimensDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Benedikt WestphalenComprehensive Cancer Center Munich & Department of Medicine III, Ludwig-Maximilian University of Munich, Munich, Germany.
Paul HofmanLaboratory of Clinical and Experimental Pathology, Hospital-Related Biobank BB0033-00025, Nice University Hospital, University Côte d'Azur, FHU OncoAge, IHU RespirERA, 06000, Nice, France.

Funding

Agence Nationale de la Recherche ANR-23-IAHU-007
6 · The paper itself

Abstract

Despite advancements in precision medicine, many cancer patients globally, particularly those in resource-constrained environments, face significant challenges in accessing high-quality molecular testing and targeted therapies. The considerable heterogeneity in molecular testing highlights the urgent need to harmonize practices across Europe and beyond, establishing a more standardized and consistent approach in MP laboratories. Professionals, especially molecular pathologists, must move beyond traditional education to cope with this heterogeneity. This perspective addresses critical issues in molecular pathology (MP), such as limited access to high-quality molecular testing, leading to disparities in cancer treatment, and the consequences of inconsistent practices. Recognizing the necessity for a standardized framework for education to address these issues, educational programs play a pivotal role in updating professionals' skills to achieve standardization in MP. European experts from the Steering Committee, the Pathology Section of the European Union of Medical Specialists, and the European Society of Pathology have proposed creating a comprehensive Master's degree program called the "European Masters in Molecular Pathology" (EMMP). This program emerges as a strategic response to the demand for a specialized and standardized framework for education in MP, catering to professionals who concurrently work and study. The program's design aligns with evidence-based education methods, ensuring effective learning and engagement while integrating computational pathology to analyze complex molecular data, enhance diagnostic accuracy, and improve treatment outcomes. EMMP's structured curriculum, strategic partnerships, and regular updates underscore its significance in standardizing MP practices. Exploring future developments, this perspective delves into technology integration and interdisciplinary collaboration, anticipating ongoing advances and harmonization. Challenges and future directions in MP education are discussed, emphasizing the necessity for dynamic curriculum updates, seamless technology integration, and interdisciplinary cooperation. This perspective underscores EMMP's pivotal role in preparing pathologists for this dynamic field, advocating continuous advancements in education and training to uphold excellence in MP practices and maintain the highest patient care standards.

Indexed as

CurriculumPathology, MolecularEducation, Medical, GraduateEuropeHumansPathologistsEducationEuropeMastersMolecular pathologyStandardization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.